Picard Medical Regains Compliance with NYSE Standards
Picard Medical (PMI) has been accepted by the NYSE American to regain compliance with its continued listing standards. The company was granted a compliance period through November 8, 2027, allowing it time to meet all necessary requirements for maintaining its exchange listing. To support this effort, Picard recently approved a 1-for-50 reverse stock split. This move is intended to increase the per-share price and help maintain regulatory compliance with NYSE American's minimum standards. The company has been under pressure due to financial challenges that previously threatened its continued presence on the exchange. The announcement comes amid ongoing efforts by Picard Medical, including a recent CEO transition and interim leadership appointment, as it seeks stability in both governance and market performance.
Tickers: $PMI